A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Public ClinicalTrials.gov record NCT02076399. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Study identification
- NCT ID
- NCT02076399
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Rigel Pharmaceuticals
- Industry
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Interventions
- Fostamatinib disodium Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 13, 2014
- Primary completion
- Apr 20, 2016
- Completion
- Apr 20, 2016
- Last update posted
- Feb 11, 2019
2014 – 2016
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates | Tucson | Arizona | 85710 | — |
| University of Southern California | Los Angeles | California | 90089 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33805-1965 | — |
| Bleeding & Clotting Disorders Institute | Peoria | Illinois | 61614 | — |
| Horizon Oncology Research, Inc | Lafayette | Indiana | 47905 | — |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| Weill Cornell Medical College/New York Presbyterian Hospital | New York | New York | 10065 | — |
| Pitt County Memorial Hospital | Greenville | North Carolina | 27858 | — |
| Bill Hefner VA Medical Center | Salisbury | North Carolina | 28144 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Signal Point Clinical Research Center LLC | Middletown | Ohio | 45042 | — |
| University of Utah Health Sciences Center | Salt Lake City | Utah | 84132 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02076399, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02076399 live on ClinicalTrials.gov.